We are a thriving and ambitious research community tackling some of the world's biggest health care challenges. Our research is contributing to better treatments to fight malaria, cancer, autoimmune disease, dementia, neglected diseases and antibiotic resistance.
We work in the following areas:
- drug candidate optimisation
- drug delivery, disposition and dynamics
- drug discovery biology
- medicinal chemistry
- medicine use and safety.
- pharmacy and pharmaceutical sciences education
World-class research infrastructure
As a graduate researcher you will have access to advanced research platforms that will enable, enhance and extend your research. Across Monash you can access a strong and extensive integrated network of research platforms. On the Parkville campus alone we have to comprehensive imaging facilities and a number of integrated world-class research platforms including:
- The Centre for Drug Candidate Optimisation providing drug candidate optimisation services and support to emerging drug discovery and development programs.
- The Australian Translational Medicinal Chemistry Facility translating new discoveries in disease biology into suitably targeted therapeutics for clinical development.
- The HMST laboratory with open access, state-of-the-art analytical laboratory providing sophisticated physical and chemical characterisation techniques.
- The Monash Fragment Platform provides researchers with access to fragment-based drug discovery (FBDD) technologies for their therapeutic targets.
Collaborations and networks to extend your thinking and opportunities
Our international campuses, alliances and partnerships make us an international university. Our doctoral program is your chance to utilise these networks and form your own. We collaborate with companies like GlaxoSmithKline, Takeda, Capsugel and Servier Pharmaceuticals to help develop and refine pharmaceutical interventions that benefit our community.
Our international connections also include the PharmAlliance partnership which means we collaborate with the University of North Carolina at Chapel Hill and University College London on transformative research and education initiatives.